-
摘要: 急性心肌梗死(acute myocardial infarction，AMI)在世界范围内的发病率和病死率逐年上升，随着再灌注治疗的开展，AMI患者的病死率降低，但依然高发AMI后心力衰竭等不良事件。AMI造成的心脏损伤是不良心血管事件发生的基础，如何修复心脏损伤一直是心血管领域研究的重点，因此，探讨AMI后的心脏损伤修复具有重要意义。本文对AMI后心脏损伤修复的研究进展进行综述，旨在为AMI提供新的治疗思路，以改善预后。Abstract: The morbidity and mortality due to acute myocardial infarction(AMI) worldwide are increasing year by year. With the development of reperfusion therapy, the mortality of AMI patients has decreased, however, there is still a high incidence of adverse events such as heart failure after AMI. Heart injury caused by AMI is the basis of adverse cardiovascular events. How to repair heart damage has always been the focus of research in the cardiovascular field. Therefore, it is of great significance to explore the repair of cardiac injury after AMI. This article reviews the research progress of cardiac injury repair after AMI, aiming to provide new treatment ideas for AMI and improve prognosis.
-
-
[1] 马逸夫, 刘婷婷, 孙芳玲, 等. 心肌梗死后心肌再生相关调节机制的研究进展[J]. 中国医药导报, 2021, 18(36): 40-44. doi: 10.3969/j.issn.1673-7210.2021.36.yycyzx202136009
[2] Dagenais GR, Leong DP, Rangarajan S, et al. Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents(PURE): a prospective cohort study[J]. Lancet, 2020, 395(10226): 785-794. doi: 10.1016/S0140-6736(19)32007-0
[3] Kologrivova I, Shtatolkina M, Suslova T, et al. Cells of the Immune System in Cardiac Remodeling: Main Players in Resolution of Inflammation and Repair After Myocardial Infarction[J]. Front Immunol, 2021, 12: 664457. doi: 10.3389/fimmu.2021.664457
[4] Prabhu SD, Frangogiannis NG. The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis[J]. Circ Res, 2016, 119(1): 91-112. doi: 10.1161/CIRCRESAHA.116.303577
[5] Silvis M, Kaffka Genaamd Dengler SE, Odille CA, et al. Damage-Associated Molecular Patterns in Myocardial Infarction and Heart Transplantation: The Road to Translational Success[J]. Front Immunol, 2020, 11: 599511. doi: 10.3389/fimmu.2020.599511
[6] Daseke MJ 2nd, Chalise U, Becirovic-Agic M, et al. Neutrophil signaling during myocardial infarction wound repair[J]. Cell Signal, 2021, 77: 109816. doi: 10.1016/j.cellsig.2020.109816
[7] Horckmans M, Ring L, Duchene J, et al. Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype[J]. Eur Heart J, 2017, 38(3): 187-197.
[8] Ma Y, Iyer RP, Jung M, et al. Cardiac Fibroblast Activation Post-Myocardial Infarction: Current Knowledge Gaps[J]. Trends Pharmacol Sci, 2017, 38(5): 448-458. doi: 10.1016/j.tips.2017.03.001
[9] Puhl SL, Steffens S. Neutrophils in Post-myocardial Infarction Inflammation: Damage vs. Resolution?[J]. Front Cardiovasc Med, 2019, 6: 25. doi: 10.3389/fcvm.2019.00025
[10] Andreadou I, Cabrera-Fuentes HA, Devaux Y, et al. Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities[J]. Cardiovasc Res, 2019, 115(7): 1117-1130. doi: 10.1093/cvr/cvz050
[11] Jiang K, Tu Z, Chen K, et al. Gasdermin D inhibition confers antineutrophil-mediated cardioprotection in acute myocardial infarction[J]. J Clin Invest, 2022, 132(1): e151268. . doi: 10.1172/JCI151268
[12] 王圣洁, 孙丽华. 心肌梗死后炎症反应研究现状[J]. 中国临床药理学杂志, 2021, 37(24): 3374-3378. doi: 10.13699/j.cnki.1001-6821.2021.24.018
[13] Peet C, Ivetic A, Bromage DI, et al. Cardiac monocytes and macrophages after myocardial infarction[J]. Cardiovasc Res, 2020, 116(6): 1101-1112. doi: 10.1093/cvr/cvz336
[14] Pavlou S, Lindsay J, Ingram R, et al. Sustained high glucose exposure sensitizes macrophage responses to cytokine stimuli but reduces their phagocytic activity[J]. BMC Immunol, 2018, 19(1): 24. doi: 10.1186/s12865-018-0261-0
[15] 杨帅涛, 廖杰, 杜以梅. 巨噬细胞在心室重塑中的作用[J]. 临床心血管病杂志, 2021, 37(4): 304-308. doi: 10.13201/j.issn.1001-1439.2021.04.004
[16] Zhang X, Li M, Yin N, et al. The Expression Regulation and Biological Function of Autotaxin[J]. Cells, 2021, 10(4): 939. doi: 10.3390/cells10040939
[17] Igarashi H, Akahoshi N, Ohto-Nakanishi T, et al. The lysophosphatidic acid receptor LPA4 regulates hematopoiesis-supporting activity of bone marrow stromal cells[J]. Sci Rep, 2015, 5: 11410. doi: 10.1038/srep11410
[18] Tripathi H, Al-Darraji A, Abo-Aly M, et al. Autotaxin inhibition reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction[J]. J Mol Cell Cardiol, 2020, 149: 95-114. doi: 10.1016/j.yjmcc.2020.09.011
[19] Maher TM, van der Aar EM, Van de Steen O, et al. Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis(FLORA): a phase 2a randomised placebo-controlled trial[J]. Lancet Respir Med, 2018, 6(8): 627-635. doi: 10.1016/S2213-2600(18)30181-4
[20] Mia MM, Cibi DM, Abdul Ghani S, et al. YAP/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction[J]. PLoS Biol, 2020, 18(12): e3000941. doi: 10.1371/journal.pbio.3000941
[21] Huang CK, Dai D, Xie H, et al. Lgr4 Governs a Pro-Inflammatory Program in Macrophages to Antagonize Post-Infarction Cardiac Repair[J]. Circ Res, 2020, 127(8): 953-973. doi: 10.1161/CIRCRESAHA.119.315807
[22] Seong E, Lee JH, Lim S, et al. Activation of Aryl Hydrocarbon Receptor by ITE Improves Cardiac Function in Mice After Myocardial Infarction[J]. J Am Heart Assoc, 2021, 10(13): e020502. doi: 10.1161/JAHA.120.020502
[23] Ricci C, Ruscica M, Camera M, et al. PCSK9 induces a pro-inflammatory response in macrophages[J]. Sci Rep, 2018, 8(1): 2267. doi: 10.1038/s41598-018-20425-x
[24] Wang F, Li M, Zhang A, et al. PCSK9 Modulates Macrophage Polarization-Mediated Ventricular Remodeling after Myocardial Infarction[J]. J Immunol Res, 2022: 7685796.
[25] Wu X, Reboll MR, Korf-Klingebiel M, et al. Angiogenesis after acute myocardial infarction[J]. Cardiovasc Res, 2021, 117(5): 1257-1273. doi: 10.1093/cvr/cvaa287
[26] Nakada Y, Canseco DC, Thet S, et al. Hypoxia induces heart regeneration in adult mice[J]. Nature, 2017, 541(7636): 222-227. doi: 10.1038/nature20173
[27] Glinton KE, Ma W, Lantz C, et al. Macrophage-produced VEGFC is induced by efferocytosis to ameliorate cardiac injury and inflammation[J]. J Clin Invest, 2022, 132(9): e140685. doi: 10.1172/JCI140685
[28] Frangogiannis NG. The extracellular matrix in myocardial injury, repair, and remodeling[J]. J Clin Invest, 2017, 127(5): 1600-1612. doi: 10.1172/JCI87491
[29] Reboll MR, Klede S, Taft MH, et al. Meteorin-like promotes heart repair through endothelial KIT receptor tyrosine kinase[J]. Science, 2022, 376(6599): 1343-1347. doi: 10.1126/science.abn3027
[30] Pei J, Cai L, Wang F, et al. LPA(2) Contributes to Vascular Endothelium Homeostasis and Cardiac Remodeling After Myocardial Infarction[J]. Circ Res, 2022, 131(5): 388-403. doi: 10.1161/CIRCRESAHA.122.321036
[31] 杜冲, 韦天文, 李亚飞, 等. 心肌梗死后心肌细胞内源性再生的研究进展[J]. 心血管病学进展, 2020, 41(4): 395-399. https://www.cnki.com.cn/Article/CJFDTOTAL-XXGB202004017.htm
[32] Qiu CW, Liu ZY, Zhang FL, et al. Post-stroke gastrodin treatment ameliorates ischemic injury and increases neurogenesis and restores the Wnt/β-Catenin signaling in focal cerebral ischemia in mice[J]. Brain Res, 2019, 1712: 7-15. doi: 10.1016/j.brainres.2019.01.043
[33] Hu Z, Chen P, Wang L, et al. FGF6 promotes cardiac repair after myocardial infarction by inhibiting the Hippo pathway[J]. Cell Prolif, 2022, 55(5): e13221.
[34] Wang J, Gu S, Liu F, et al. Reprogramming of fibroblasts into expandable cardiovascular progenitor cells via small molecules in xeno-free conditions[J]. Nat Biomed Eng, 2022, 6(4): 403-420. doi: 10.1038/s41551-022-00865-7
[35] Du J, Zheng L, Gao P, et al. A small-molecule cocktail promotes mammalian cardiomyocyte proliferation and heart regeneration[J]. Cell Stem Cell, 2022, 29(4): 545-558. doi: 10.1016/j.stem.2022.03.009
[36] 刘牧吟, 戴春峰, 陈章炜, 等. 秋水仙碱防治冠心病的研究进展[J]. 中华心血管病杂志, 2022, 50(6): 606-610.
[37] 张进. 重组人脑利钠肽在改善急性心肌梗死患者心功能中的应用价值[J]. 心血管病防治知识, 2022, 12(7): 20-23. https://www.cnki.com.cn/Article/CJFDTOTAL-XUGB202207007.htm
[38] Fang J, Zeng W. A meta-analysis of the clinical efficacy of rhBNP in treating patients with acute myocardial infarction and heart failure[J]. Am J Transl Res, 2021, 13(4): 2410-2421.
[39] 纪焕春, 姚福梅, 王霞, 等. 益气宁心汤联合重组人脑利钠肽治疗急性心肌梗死伴心力衰竭的临床研究[J]. 中西医结合心脑血管病杂志, 2022, 20(1): 95-99. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYY202201018.htm
[40] 张敏州, 丁邦晗, 林谦. 急性心肌梗死中医临床诊疗指南[J]. 中华中医药杂志, 2021, 36(7): 4119-4127. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202107088.htm
[41] 代培方, 任蓁, 牛雯颖, 等. 益气养阴方对急性心肌缺血模型大鼠的保护作用[J]. 中医药信息, 2022, 39(4): 41-46. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXN202204008.htm
-
下载:
图(1)
计量
- 文章访问数: 1001
- PDF下载数: 190
- 施引文献: 0